Matches 1 - 50 out of 295 1 2 3 4 5 6 >

CobaltIP-faceted-search-demo
Match Document Document Title
8173638 Compounds which modulate the CB2 receptor  
Compounds of formula (I) are disclosed. Compounds according to the invention bind to and are agonists, antagonists or inverse agonists of the CB2 receptor, and are useful for treating inflammation....
8013156 Tie-2 modulators and methods of use  
The present invention provides compounds for modulating protein kinase enzymatic activity for modulating cellular activities such as proliferation, differentiation, programmed cell death, migration...
7951807 Substituted oxindol derivatives and medicaments containing the same  
The present invention relates to novel oxindole derivatives of the general formula (I), wherein the substituents A, B, R1, R2 and R3 are as defined in Claim 1, and medicaments containing the same...
7919618 Synthesis of piperazines, piperidines and related compounds  
Novel methods of synthesizing piperazines, piperidines and related compounds are disclosed, as are compounds useful for their preparation.
7888384 Heterocyclic derivatives for modulation of calcium channels  
Heterocyclic derivatives act as Ca channel antagonists. The compositions are useful for treating or relieving Ca channel mediated conditions.
7829560 1,4-disubstituted naphthalenes as inhibitors of P38 MAP kinase  
1,4 disubstituted napthylenes, of formula (I), are disclosed. These compounds may be useful in treating cell-proliferative diseases.
7727989 4-benzimidazol-2-yl-pyridazine-3-one-derivatives, production and use thereof in medicaments  
The present invention relates to kinase inhibitor compounds and derivatives thereof as well as compositions comprising them consisting of the structure of formula I: Wherein R1, R2, A, B, D and E...
7709466 Pyridazinone derivatives, methods for their production and their use as pharmaceuticals  
The present invention relates to pyridazinone compounds and their derivatives according to the general formula (I), with the substituents X, R1 and R2 defined herein, as well as their...
7709467 Apoptosis promoters  
Compounds which inhibit the activity of anti-apoptotic family protein members, compositions containing the compounds and methods of treating diseases during which occur expression one or more than...
7704995 Protein kinase modulators and methods of use  
This invention relates to compounds for modulating protein kinase enzymatic activity for modulating cellular activities such as proliferation, differentiation, programmed cell death, migration and...
7514424 Substituted 4-(4-piperidin-4-yl-piperazin-1-yl)-azepane derivatives and their use as neurokinin antagonists  
The invention concerns substituted 4-(4-piperidin-4-yl-piperazin-1-yl)-azepane derivatives having neurokinin antagonistic activity, in particular NK˜antagonistic activity, their preparation, ...
7432255 1H-indol-5-yl-piperazin-1-yl-methanone derivatives  
The present invention relates to compounds of formula I and their pharmaceutically acceptable salts wherein in formula I is: wherein R1 to R4 are as defined in the description and claims. The...
7427612 Benzoyl-piperazine derivatives  
A compound of formula wherein the substituents are as described in the specification for the treatment of psychoses, pain, neurodegenerative disfunction in memory and learning, schizophrenia,...
7405209 Protease inhibitors  
The present invention provides 4-amino-azepan-3-one protease inhibitors and pharmaceutically acceptable salts, hydrates and solvates thereof which inhibit proteases, including cathepsin K,...
7393845 Heteroaryl derivates, their preparation and use  
A heteroaryl derivative having the formula (I). The compounds of the invention are considered useful for the treatment of affective disorders such as general anxiety disorder, panic disorder,...
7348425 Inhibitors of HCV replication  
Indole compounds of Formula I are described. The compounds have activity against hepatitis C virus (HCV) and are useful in treating those infected with HCV. Different forms and compositions...
7244722 Amino-substituted 1H-pyrazin-2-ones and 1H-quinoxalin-2-ones  
Compounds of the general formula (I): wherein m, n, R1, R2, R3 and R4 are as described in the specification. Further included are pharmaceutical compositions comprising the compounds, processes for...
7238688 Piperidine compounds  
Disclosed are novel compounds of the formula Also disclosed are pharmaceutical compositions comprising the compounds of Formula I.Also disclosed are methods of treating various diseases or...
7186827 Dipeptide synthesis  
Disclosed are processes of making dipeptide compounds of formula(I) as further described in the detailed description section:
7071184 Protease inhibitors  
The present invention provides C1-6alkyl-4-amino-azepan-3-one protease inhibitors and pharmaceutically acceptable salts, hydrates and solvates thereof which inhibit proteases, including cathepsin...
6960575 Thiazine derivatives  
A compound having 3-oxo-3, 4-dihydro-2H-1, 4-thiazine 4-tetrahydropyrazine as a main skeleton. The compound is a chymase inhibitor and is represented by the following formula [I] and salts thereof:...
6890921 Arylsubstituted piperazines useful in the treatment of benign prostatic hyperplasia  
This invention relates to a series of arylsubstituted piperazines, of Formula I pharmaceutical compositions containing them and intermediates used in their manufacture. The compounds of the...
6887864 Azepane derivatives  
This invention provides novel azepane derivatives or pharmaceutically acceptable salts thereof, according to the general formula (I) wherein the symbols are defined in the specification, as well as...
6846827 Pyrimidine derivatives  
The invention concerns pyrimidine derivatives of Formula (I) wherein m is 0-3 and each R1 is a group such as hydroxy, halogeno, trifluoromethyl and cyano; R3 is hydrogen, halogeno or (1-6C)alkyl; n...
6821965 Amidobenzamide derivatives which are useful as cytokine inhibitors  
The invention concerns amide derivatives of the Formula (I) wherein R3 is (1-6C)alkyl or halogeno; Q is aryl or heteroaryl which optionally bears 1, 2, 3 or 4 substituents such as hydroxy,...
6800636 Farnesyl protein transferase inhibitors  
Disclosed are compounds of the formula: wherein R8 represents a cyclic moiety to which is bound an imodazolylalkyl group; R9 represents a carbamate, urea, amide or sulfonamide group; and the...
6767907 4-aryl-1-(indanmethyl dihydrobenzofuranmethyl or dihydrobenzothiophenemethyl) piperidines tetrahydropyridines or piperazines  
4-Aryl-1-(indanmethyl, dihydrobenzofuranmethyl or dihydrobenzothiophenemethyl)piperidine, -tetrahydropyridine or -piperazine compounds of general formula (I), wherein one of X and Y is CH2 and the...
6743788 Carbamate and oxamide compounds  
Disclosed are novel aromatic compounds of the formula(I) described herein, wherein G, E, W, Ar, X, Y and Z are disclosed herein. The compounds are useful for treating cytokine mediated diseases or...
6713472 Thiazine or pyrazine derivatives  
A compound which is a chymase inhibitor and which is represented by a formula [I] and salts thereof. In the formula [I], X is R6—(A2)n—N, R1 and R2 are H, alkyl, cycloalkyl or aryl, R3 and R4 are...
6710042 Human NK3 receptor-selective antagonist compounds, method for obtaining them and pharmaceutical compositions containing them  
Compounds of formula (I) are useful as human NK3 receptor antagonists.
6699856 Pyrazinones, compositions containing such compounds and methods of use  
Compounds represented by formula I: as well as pharmaceutically acceptable salts, esters, N-oxides and hydrates thereof are disclosed. Pharmaceutical compositions and methods of use are also...
6699864 Substituted phenyl-piperazine derivatives, their preparation and use  
The present invention provides compounds of the formula: wherein R1-R8, X, Y, Z, n and m are defined in the application.The compounds of the invention have affinity for the 5-HT1A receptor.
6639070 N-substituted perhydrodiazine  
N-substituted perhydro-2,3-diazines of the formula I in which the variables Z, R, m and RA are as defined in claim 1, a process for their preparation and the use of the compounds of the formula I...
6583136 Antifungal ethers  
The present invention concerns compounds of formula the N-oxide forms, the salts, the quaternary amines and stereochemically isomeric forms thereof, whereinD represents a tetrahydrofuran or...
6455520 Benzamide derivatives and their use as cytokine inhibitors  
The invention concerns amide derivatives of formula (I) wherein R3 is (1-6C)alkyl or halogeno; m is 0-3, p is 0-2 and q is 0-4; each of R1 and R2 is a group such as hydroxy, halogeno,...
6420395 Azacyclooctane and heptane derivatives, their preparation and use in therapy  
The present invention discloses compounds of formula (1) or (2), any of its enantiomers or any mixture thereof, or a pharmaceutically acceptable salt thereof; wherein n is 0, or 1; R is hydrogen,...
6372440 Method for detecting deficient cellular membrane tightly bound magnesium for disease diagnoses  
This invention relates to methods for detecting the deficiency of magnesium tightly bound to cellular membranes, i.e. magnesium binding defect, which deficiency is associated with certain abnormal...
6355640 Pyrazolopyridine adenosine antagonists  
The present invention relates to a novel pyrazolopyridine compound of the following formula: whereinR1 is aryl, andR2 is cyclo(lower)alkyl which may have one or more suitable substituent(s),...
6352981 Substituted AZA- and diazacycloheptane and -cyclooctane  
Aza- and diazacyclohexane and -cyclooctane compounds of the following formula: Ar1—A—B—Ar2 (I)where Ar1, A, B and Ar2 have the meanings stated in the description have a high affinity for the dopam...
6329380 SRC kinase inhibitor compounds  
Pyrimidine compounds (Formula I), or their pharmaceutically acceptable salts, hydrates, solvates, crystal forms and individual diastereomers, and pharmaceutical compositions including the same,...
6316444 SRC kinase inhibitor compounds  
Pyrimidine compounds (Formula I), or their pharmaceutically acceptable salts, hydrates, solvates, crystal forms and individual diastereomers, and pharmaceutical compositions including the same,...
6303594 ***WITHDRAWN PATENT AS PER THE LATEST USPTO WITHDRAWN LIST***
Arylsubstituted piperazines useful in the treatment of benign prostatic hyperplasia
 
This invention relates to a series of arylsubstituted piperazines, of Formula I ##STR1##pharmaceutical compositions containing them and intermediates used in their manufacture. The compounds of the...
6288059 Acylated hetero-alicyclic derivatives  
A compound of formula (I), a pharmaceutically acceptable salt or ester or other derivative thereof: ##STR1##R1 is optionally substituted cycloalkyl or optionally substituted saturated heterocyclic...
6265348 Alkylidenehydrazinophenylsulfonylureas, processes for their preparation and their use as herbicides and plant growth regulators  
Compounds of the formula (I) and salts thereof ##STR1##in which R1 to R6, W, X, Y and Z are defined as in claim 1, have herbicidal or plant growth-regulatory properties.They can be prepared by...
6255302 1,4-piperazine derivatives  
Compounds of the formula ##STR1##are useful for the treatment of disorder of the central nervous system including anxiety, depression, panic, alcohol and drug addiction, sexual dysfunction, sleep...
6221858 Pyridyl-and pyrimidyl-piperazines in the treatment of substance abuse disorders  
6218394 4-Aryl-1-(indanmethyl, dihydrobenzofuranmethyl or dihydrobenzothiophene-methyl) piperazines  
4-Aryl-1-(indanmethyl, dihydrobenzofuramethyl or dihydrobenzothiophenemethyl) piperidine, -tetrahydropyridine or -piperazine compounds of general formula (I) ##STR1##wherein one of X and Y is CH2,...
6174940 Synergistic stabilizer mixture based on polyalkyl-1-oxa-diazaspirodecane compounds  
The present invention relates to mixtures comprising the compound I in a proportion of 65-95% by weight, the compound II in a proportion of 5-35% by weight and the compound III in a proportion of...
6127357 N-((phenyl, benzodioxinyl or N-heteroarylpiperazinyl)alkyl)-N-(N-heteroaryl)substituted carboxamides  
Piperazine derivatives of formula I ##STR1## and their pharmaceutically acceptable acid addition salts are 5-HT1A binding agents, particularly 5-HT1A antagonists and may be used, for example, as...
6069114 2-amino-4-bicycloamino-1,3,5-Triazines, their preparation, and their use as herbicide and plant growth regulators  
Compounds of the formula (I) and their salts ##STR1## in which R1 to R6, Y1, to Y2, Y3, m and n are as defined in claim 1 are suitable as herbicides and plant growth regulators. They can be...
Matches 1 - 50 out of 295 1 2 3 4 5 6 >